Adherence
Using Data to Drive Patient Adherence, Population Health, and Brand Revenues
When pharma brands send patients or prescribers a message about reducing medication costs, how ...
Harnessing the Power of Mobile Patient Support for Patient Adherence
As the healthcare system continues to shift toward finding ways to support and inform ...
An Evolving Healthcare Ecosystem: Pharma’s Role in Solving SDoH and Health Equity Issues
The 16th Century English phrase, “A Jack of all trades is a master of ...
Driving Adherence with Point-of-Care Marketing
It’s no secret that drug adherence is a major problem, not only for patients, ...
Examining the Impact of COVID on Adherence and the Path Forward
One of the major concerns during the early days of the pandemic was how ...
Two Key Questions About Adherence/Compliance in 2021
PM360 asked experts in helping patients adhere to their treatment regimens how COVID will ...
8 of the Latest Solutions and Strategies to Improve Adherence
Each year, medication nonadherence costs the U.S. healthcare system hundreds of billions of dollars. ...
In-Workflow Tools Are Changing the Provider-Patient Conversation and Driving Adherence
For patients struggling with a serious medical condition, finally finding an effective treatment and ...
Why People with Diabetes are Hit Harder by COVID-19—And How to Help Them
As we continue to learn more about COVID-19 and its long-term effects, it’s clear ...
Digitizing the Healthcare Provider Experience
When brands can find innovative ways to help relieve providers of administrative burdens that take away from ...
The Problem with the Current Gold Standard for Measuring Adherence
“What gets measured gets managed” is one of the most commonly used business mantras ...
How Cancer Patients Feel About Novel Medication Adherence Programs
Medication adherence programs using gamification, rewards, and other positive digital strategies have been implemented ...
Three Tips for Successful Digital Companion Programs
As COVID-19 accelerated the use of digital companions, pharma now has a glimpse into ...
